GW Pharmaceuticals plc (GWPH) Jumps: Stock Rises 7.6%

Zacks Equity Research

GW Pharmaceuticals plc (GWPH) was a big mover last session, as the company saw its shares rise by roughly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 55% in the past one-month time frame.

This drug manufacturer has seen one negative revision in the past 30 days and its Zacks Consensus Estimate moved lower over the time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

GW Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include NuVasive, Inc. (NUVA), Covidien plc (COV) and PositiveID Corporation (PSID). While NuVasive holds a Zacks Rank #1 (Strong Buy), Covidien and PositiveID carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




GW PHARMACEUTICALS PLC ADS (GWPH): Free Stock Analysis Report

NUVASIVE INC (NUVA): Free Stock Analysis Report

COVIDIEN PLC NEW (COV): Free Stock Analysis Report

POSITIVEID CORPORATI (PSID): Free Stock Analysis Report


Zacks Investment Research